Precigen (PGEN) Current Deferred Revenue (2012 - 2026)

Precigen (PGEN) has reported Current Deferred Revenue for 15 consecutive years, with $410000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 82.81% year-over-year to $410000.0; the TTM figure through Mar 2026 stood at $410000.0 (down 82.81% YoY), while the FY2025 annual figure was $517000.0, down 12.22% from the prior year.
• Current Deferred Revenue declined to $410000.0 in Q1 2026 per PGEN's latest filing, from $517000.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $2.7 million in Q1 2022 and bottomed at $15000.0 in Q2 2023.
• Historically, Current Deferred Revenue has averaged $1.0 million across 5 years, with a median of $509000.0 in 2023.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue plunged 99.9% — and 2024, when it surged 2420.0%.
• Precigen's Current Deferred Revenue stood at $25000.0 in 2022, then soared by 1936.0% to $509000.0 in 2023, then gained by 15.72% to $589000.0 in 2024, then fell by 12.22% to $517000.0 in 2025, then declined by 20.7% to $410000.0 in 2026.
• Business Quant data shows PGEN's Current Deferred Revenue at $410000.0 in Q1 2026, $517000.0 in Q4 2025, and $480000.0 in Q3 2025.